Roszet® is indicated for adults with Primary Non-familial Hyperlipidemia and Homozygous Familial Hypercholesterolemia - Roszet is a powerful and affordable way to significantly lower patients' cholesterol -- Up to 72% LDL-C reduction expected from ...
TARRYTOWN, N.Y. , Feb. 11, 2021 /PRNewswire/ -- Homozygous familial hypercholesterolemia ( HoFH) is an ultra-rare inherited condition that affects approximately 1,300 patients in the U.S. and is characterized by extremely high ...
TARRYTOWN, N.Y. , Aug. 19, 2020 /PRNewswire/ -- Patients with homozygous familial hypercholesterolemia (HoFH) suffer from a severe form of early cardiovascular disease and are inadequately served by currently available medications ...
TARRYTOWN, N.Y. , Aug. 12, 2020 /PRNewswire/ -- Homozygous familial hypercholesterolemia affects approximately 1,300 patients in the U.S., the vast majority of whom are unable to reach target LDL-C levels with currently available therapies ...
As high drug prices continue to incite public outcry and US legislation, it is nonetheless possible that Regeneron Pharmaceuticals’ drug for a rare cholesterol condition could lock in as much as USD500,000 annually, according to reporting from ...
North Carolina Central University Associate Professor Dayami Lopez, Ph.D., was awarded a $1.48 million grant from the National Institute for General Medical Sciences to study new means of treating high cholesterol and preventing heart disease. ...
Imagine Global Care Corp, a life sciences company developing natural, clinically tested health and wellness products based on phytonutrient research, today announced the publication of the first clinical trial of its recently launched bitter melon ...
Organizations Committed to Highest of Standards and Quality in Patient Spiritual Care NEW YORK , Nov. 17, 2018 /PRNewswire-PRWeb/ -- The Academy of Holistic Theology & Spirituality presented the Rev. Eric J. Hall , M.A., M.Div. with a ...
1 Tresiba® (insulin degludec injection), Novo Nordisk Canada Inc., Product Monograph, August 25, 2017. 2 Haahr H, Heise T. A review of the ...
NEW YORK , Feb. 16, 2017 /PRNewswire/ -- S ummary The Hypercholesterolemia Partnering 2010-2015 report provides understanding and access to the hypercholesterolemia partnering deals and agreements entered into by the worlds leading ...
Over 70% of American Indian young adults (20-39 years old) and 50% of American Indian teenagers exhibit cholesterol levels or elevated blood fat, posing a risk for cardiovascular disease ...
When you accidentally stub your toe or hit your head, you're familiar with the instinct to rub the area for relief. But why does this work? Recent findings from the laboratory of Scott B. Hansen, Ph.D., illustrate how applying physical pressure on cells can diminish pain signals. Conversely, the research reveals that excessive cholesterol clusters in cell membranes may disrupt this pain-relief process. ...
Scientists have developed a groundbreaking vaccine offering a cost-effective approach to lower "bad" LDL cholesterol, responsible for perilous plaques that may obstruct blood vessels . ...
Among older adults, both elevated and reduced levels of high-density lipoprotein (HDL) cholesterol, often referred to as "good" cholesterol , are associated with a slight uptick in dementia risk, ...
A novel medicine, muvalaplin provides a ground-breaking, world’s first-ever treatment for lipoprotein(a), a predisposed form of cholesterol that raises the risk of heart attack and stroke ....
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers